157 related articles for article (PubMed ID: 35232626)
1. PML isoforms: a molecular basis for PML pleiotropic functions.
Uggè M; Simoni M; Fracassi C; Bernardi R
Trends Biochem Sci; 2022 Jul; 47(7):609-619. PubMed ID: 35232626
[TBL] [Abstract][Full Text] [Related]
2. Swine Promyelocytic Leukemia Isoform II Inhibits Pseudorabies Virus Infection by Suppressing Viral Gene Transcription in Promyelocytic Leukemia Nuclear Bodies.
Yu C; Xu A; Lang Y; Qin C; Wang M; Yuan X; Sun S; Feng W; Gao C; Chen J; Zhang R; Tang J
J Virol; 2020 Aug; 94(18):. PubMed ID: 32641476
[TBL] [Abstract][Full Text] [Related]
3. The promyelocytic leukemia protein isoform PML1 is an oncoprotein and a direct target of the antioxidant sulforaphane (SFN).
Alhazmi N; Pai CP; Albaqami A; Wang H; Zhao X; Chen M; Hu P; Guo S; Starost K; Hajihassani O; Miyagi M; Kao HY
Biochim Biophys Acta Mol Cell Res; 2020 Aug; 1867(8):118707. PubMed ID: 32243901
[TBL] [Abstract][Full Text] [Related]
4. SUMO5, a Novel Poly-SUMO Isoform, Regulates PML Nuclear Bodies.
Liang YC; Lee CC; Yao YL; Lai CC; Schmitz ML; Yang WM
Sci Rep; 2016 May; 6():26509. PubMed ID: 27211601
[TBL] [Abstract][Full Text] [Related]
5. PML Alternative Splice Products Differentially Regulate HAdV Productive Infection.
Mai J; Stubbe M; Hofmann S; Masser S; Dobner T; Boutell C; Groitl P; Schreiner S
Microbiol Spectr; 2022 Aug; 10(4):e0078522. PubMed ID: 35699431
[TBL] [Abstract][Full Text] [Related]
6. Involvement of PML-I in reformation of PML nuclear bodies in acute promyelocytic leukemia cells by leptomycin B.
Wang C; Su L; Shao YM; Chen WZ; Bu N; Hao R; Ma LY; Hussain L; Lu XY; Wang QQ; Naranmandura H
Toxicol Appl Pharmacol; 2019 Dec; 384():114775. PubMed ID: 31669778
[TBL] [Abstract][Full Text] [Related]
7. C-terminal motifs in promyelocytic leukemia protein isoforms critically regulate PML nuclear body formation.
Li C; Peng Q; Wan X; Sun H; Tang J
J Cell Sci; 2017 Oct; 130(20):3496-3506. PubMed ID: 28851805
[TBL] [Abstract][Full Text] [Related]
8. Dengue Non-structural Protein 5 Polymerase Complexes With Promyelocytic Leukemia Protein (PML) Isoforms III and IV to Disrupt PML-Nuclear Bodies in Infected Cells.
Giovannoni F; Ladelfa MF; Monte M; Jans DA; Hemmerich P; García C
Front Cell Infect Microbiol; 2019; 9():284. PubMed ID: 31456950
[TBL] [Abstract][Full Text] [Related]
9. New Evidence of the Importance of Weak Interactions in the Formation of PML-Bodies.
Fonin AV; Silonov SA; Fefilova AS; Stepanenko OV; Gavrilova AA; Petukhov AV; Romanovich AE; Modina AL; Zueva TS; Nedelyaev EM; Pleskach NM; Kuranova ML; Kuznetsova IM; Uversky VN; Turoverov KK
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163537
[TBL] [Abstract][Full Text] [Related]
10. Role of nuclear bodies in apoptosis signalling.
Krieghoff-Henning E; Hofmann TG
Biochim Biophys Acta; 2008 Nov; 1783(11):2185-94. PubMed ID: 18680765
[TBL] [Abstract][Full Text] [Related]
11. [PML isoforms and TGF-β response].
El-Asmi F; Chelbi-Alix MK
Med Sci (Paris); 2020 Jan; 36(1):50-56. PubMed ID: 32014098
[TBL] [Abstract][Full Text] [Related]
12. The functional roles of PML nuclear bodies in genome maintenance.
Chang HR; Munkhjargal A; Kim MJ; Park SY; Jung E; Ryu JH; Yang Y; Lim JS; Kim Y
Mutat Res; 2018 May; 809():99-107. PubMed ID: 28521962
[TBL] [Abstract][Full Text] [Related]
13. Requirement of PML SUMO interacting motif for RNF4- or arsenic trioxide-induced degradation of nuclear PML isoforms.
Maroui MA; Kheddache-Atmane S; El Asmi F; Dianoux L; Aubry M; Chelbi-Alix MK
PLoS One; 2012; 7(9):e44949. PubMed ID: 23028697
[TBL] [Abstract][Full Text] [Related]
14. [Structure and functions of isoforms of polyfunctional tumoral suppressor PML].
Zinov'eva MV; Vaĭshlia NA; Vinogradova TV; Kopantsev EP; Sverdlov ED
Mol Gen Mikrobiol Virusol; 2009; (2):15-21. PubMed ID: 19517805
[TBL] [Abstract][Full Text] [Related]
15. Promyelocytic leukemia (PML) nuclear bodies (NBs) induce latent/quiescent HSV-1 genomes chromatinization through a PML NB/Histone H3.3/H3.3 Chaperone Axis.
Cohen C; Corpet A; Roubille S; Maroui MA; Poccardi N; Rousseau A; Kleijwegt C; Binda O; Texier P; Sawtell N; Labetoulle M; Lomonte P
PLoS Pathog; 2018 Sep; 14(9):e1007313. PubMed ID: 30235352
[TBL] [Abstract][Full Text] [Related]
16. Recruitment of TRIM33 to cell-context specific PML nuclear bodies regulates nodal signaling in mESCs.
Sun H; Chen Y; Yan K; Shao Y; Zhang QC; Lin Y; Xi Q
EMBO J; 2023 Feb; 42(3):e112058. PubMed ID: 36524443
[TBL] [Abstract][Full Text] [Related]
17. PML-II recruits ataxin-3 to PML-NBs and inhibits its deubiquitinating activity.
Zhang Y; Shao AW; Tang J; Geng Y
Biochem Biophys Res Commun; 2021 May; 554():186-192. PubMed ID: 33798946
[TBL] [Abstract][Full Text] [Related]
18. The translation initiation factor 3 subunit eIF3K interacts with PML and associates with PML nuclear bodies.
Salsman J; Pinder J; Tse B; Corkery D; Dellaire G
Exp Cell Res; 2013 Oct; 319(17):2554-65. PubMed ID: 24036361
[TBL] [Abstract][Full Text] [Related]
19. Dynamics of component exchange at PML nuclear bodies.
Weidtkamp-Peters S; Lenser T; Negorev D; Gerstner N; Hofmann TG; Schwanitz G; Hoischen C; Maul G; Dittrich P; Hemmerich P
J Cell Sci; 2008 Aug; 121(Pt 16):2731-43. PubMed ID: 18664490
[TBL] [Abstract][Full Text] [Related]
20. Promyelocytic leukemia nuclear body-like structures can assemble in mouse oocytes.
Udagawa O; Kato-Udagawa A; Hirano S
Biol Open; 2022 Jun; 11(6):. PubMed ID: 35579421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
